Objective -
Atrial fibrillation is the most common arrhythmia. In the general population, its prevalence ranges from 0.15% to 1% and progressively increases with age; between the age of 25 and 35 years, the prevalence of atrial fibrillation may reach 0.2% to 0.3% of the adult population, and between the age of 55 and 64 years, it may reach 3 to 4%. In individuals above the age of 62 years, the prevalence of this arrhythmia may reach 5% to 9% 1 . Atrial fibrillation affects 8.8% of the individuals older than 80 years and, approximately, 40% of patients with rheumatic cardiac disease 1 . Atrial fibrillation is a common complication of several heart diseases, but it has a tendency to develop in specific conditions, of which mitral valve disease is the most common 2 . Approximately 40% of patients with mitral stenosis and 75% of those with mitral regurgitation develop atrial fibrillation 3 , which is an arrhythmia accounting for 45% to 85% of systemic thromboembolism. The brain is the most frequently affected organ, being involved in more than 2/3 of the thromboembolic events; pulmonary thromboembolism is far less frequent 3 . Treatment of atrial fibrillation associated with anticoagulation aims to regain sinus rhythm or the control of ventricular frequency. For this, in addition to pharmacological methods, interventional catheterization, implantable defibrillators, and surgery have been used. The Maze technique proposed by Cox et al 4 is the surgical procedure with the best results and has been used in several centers. More recently, the electrical isolation of pulmonary veins has been successfully proposed 5 . Prior to this, Graffigna et al 6 had already proposed left atrial isolation, a procedure in which the pulmonary veins were equally isolated.
Currently, several centers have performed mitral valve surgery associated with the Maze procedure and have been successful in 85% to 98% of the cases, in which reversion to atrial rhythm has been obtained [7] [8] [9] . Most patients undergoing mitral valve surgery and who have chronic atrial fibrillation do not revert to sinus rhythm with 379 379 bolism. The remaining 5 patients had no sequelae. Two (2.9%) patients had left atrial thrombi detected on echocardiography ( fig. 3 ). Our case series is shown in table I.
Sixteen patients received permanent postoperative anticoagulation, 6 of whom with atrial fibrillation and 10 with regular rhythm. The remaining 47 (74.6%) patients, 2 with atrial fibrillation and 45 with regular rhythm, did not undergo anticoagulation therapy (tab. I). The surgical staff did not recommend permanent postoperative anticoagulation because of previous atrial fibrillation. However, these 16 patients underwent anticoagulation either because of the presence of the prosthesis, or persistence of atrial fibrillation, or due to precaution, depending on the attending physicians.
Results
The immediate mortality rate was 7.25% (5 patients), and the late mortality rate was 1.45% (1 patient) (tab. II and fig. 4 ). The late death resulted from pulmonary embolism followed by encephalopathy, after acute renal failure, which evolved to death due to multisystem organ failure in the 2 nd postoperative month. Two (2.9%) patients were reoperated upon due to mitral lesion, as recurrence of mitral insufficienthe conventional postoperative treatment 3 . Jatene et al 10 reported in their study that 76.5% of the patients continued to have atrial fibrillation after surgical repair of the mitral lesion when this was not associated with the Maze procedure. These findings are in accordance with that of previous studies at our institution 11 . According to the report by Cox et al 12 in 1999, the technique may eliminate the risk of thromboembolic phenomena associated with atrial fibrillation. Kosakai 13 , during a 7-year period, did not observe any cases of thromboembolism in patients who obtained reversion to sinus rhythm after the Cox procedure without placement of the valve prosthesis. On the other hand, in 400 patients undergoing the conventional technique with no valve prosthesis placement, 13 (3.25%) episodes of thromboembolism occurred. In Brazil, Jatene et al 10 observed no thromboembolic phenomenon in the postoperative period of a group of 20 patients, all of whom had undergone the Maze procedure. On the other hand, thromboembolism occurred in 20% of the 35 patients in the control group, who had undergone only valvar replacement.
With a 7-year experience with the Maze procedure 14,15 , we found it worth assessing the prevalence of late thromboembolism in this series of patients at our institution, correlating it with morbidity, heart rate, and the use of anticoagulant drugs. We also assessed the occurrence of thromboembolism in the postoperative period of the modified Cox 3 procedure for atrial fibrillation secondary to mitral valve disease.
Methods
We carried out a retrospective review of the medical records and follow-up of 69 patients who had undergone the modified Cox 3 procedure for repair of atrial fibrillation and mitral valvuloplasty or mitral prosthesis placement, from January 1993 to July 1999 at the Instituto de Cardiologia do RS/Fundação Universitária de Cardiologia. The technical modification consisted of not using cryoablation, but more extensive dissection and electrocauterization.
The following parameters were analyzed: the patients' age, sex, valvar lesion, surgery performed (prosthesis or valvuloplasty), follow-up length, associated diseases, use of anticoagulation, complications or sequelae of embolism.
The mean age was 49.9±13.2 (20 to 77) years. The postoperative follow-up length ranged from 1 to 66 (mean of 31.7±19) months. Twenty-one (30.4%) patients were males and 48 were females (69.6%). The types of lesion were as follows: 33 (47.8%) mitral stenoses, 23 (33.3%) mitral insufficiencies, and 13 (18.8%) mitral double lesions ( fig. 1) . The surgeries performed were as follows: 64 (92.8%) valvuloplasties, 3 (4.3%) biological prosthesis placements, 2 (2.9%) mechanical prosthesis placements ( fig. 2) . In regard to thromboembolic events, 13% of patients (9) had had systemic embolisms prior to surgery as follows: 1 patient developed upper limb hemiparesis and left palpebral ptosis as a sequela; another patient developed dyslalia and weakness in the right lower limb; and another patient developed paresthesia in the right side of the face and in the left thumb. The 4 th patient had dysphasia due to 2 episodes of cerebral em- cy due to valvuloplasty failure, in the 10 th and 59 th postoperative months (tab. II). In regard to the current rhythm, 50 patients (73.5%) had sinus-atrial rhythm. At the time of the last clinical assessment, 10 (14.7%) patients had atrial fibrillation and 8 patients (11.8%) had atrioventricular pacemaker rhythm (tab. III and fig. 5 ).
A perioperative neurological lesion occurred and was followed by sepsis and death. No late systemic thromboembolism was observed (tab. II).
Discussion
Atrial fibrillation is, in clinical practice, the most common sustained arrhythmia. Its presence almost doubles mortality and increases the risk of cerebral stroke 5 times, as compared with the mortality of the population without the arrhythmia. In patients with rheumatic mitral stenosis, the increase in the risk of cerebral stroke may reach 18 times 1 . The major objective of our study was to assess the occurrence of late thromboembolism after the modified Cox 3 procedure, and to correlate it with clinical results and the permanent use of anticoagulation.
In regard to conversion to sinus or atrial rhythm, we found several reports in the literature, such as the study by Kim et al 16 , who reported a conversion rate to sinus rhythm of 81% in patients who had undergone the Cox-Maze 3 procedure. Jatene et al 10 , in their study evaluating cardiac rhythm in a series of 20 patients, observed reversion of atrial fibrillation to regular rhythm in all patients. Of these 20 patients, 75% had sinus rhythm and 25% had junctional rhythm. McCarthy et al 17 reported a reversion to sinus rhythm of 100% during 
